Updates and news related to prostate cancer:
What affect do eggs, dairy, and supplements have on prostate cancer?
For some men, this strategy eliminates the need for hormonal therapy.
Results of a Phase II clinical trial, published in the peer-reviewed journal Molecular Therapy, have led to a larger, multicenter trial that will soon be underway.
The phase 3 CHART study reveals better survival with rezvilutamide plus androgen deprivation therapy vs bicalutamide and androgen deprivation therapy in metastatic, hormone-sensitive prostate cancer.
Study Assessing Safety, Efficacy of Experimental Treatment in Metastatic Prostate Cancer Adds Additional Trial Sites
The study investigators will review the efficacy of [Lu-177]-PNT2002, a radioligand treatment, compared with Zytiga or Xtandi in patients with metastatic castration-resistant prostate cancer.
Combination Treatment Improves Progression-Free Survival in Patients with Oligometastatic Prostate Cancer
Metastasis-directed therapy (MDT) involves direct local treatment of metastatic lesions through surgery or radiation, with the goal of killing all cancer cells in that location.
Hypofractionation matches standard RT for survival and toxicity in a third less time.
A new study, involving more than 5 million men over age 40 at 128 VA facilities across the country between 2005 and 2019, found that when screening was encouraged, later diagnoses of incurable advanced malignancies were less likely.
Timing Androgen-Deprivation Therapy with Radiation Therapy Improves Outcomes in Localized Prostate Cancer
Men with prostate cancer who are receiving radiation often benefit from adding to the treatment androgen deprivation therapy, a form of medication that reduces testosterone.
If breast or ovarian cancer runs in your family, it could mean that you carry a mutation that ups your risk for prostate cancer, too.